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ABSTRACT:  The effect of alcoholic extracts of the aerial parts of fagonia cretica on estrous 
cycle and implantation in female albino rats was studied, It induced random omission of heat 
phase in eh estrous cycle and exhibited 100% anti implantation activity without exhibiting any 
toxic manifestation, However it was found to have some strong androgenic antiprogestational 
activity, and immunostimulating property. 
 
INTRODUCTION  
 
Fagonia  cretica  (Family-Zygophy-llaceae) 
commonly known in Hindi as Damahan and 
in  Sanskrit  as  Dusparsha  is  used  in  the 
Indian  system  of  medicine  as  diuretic1, 
astringent1,  in  the  treatment  of  asthma, 
tumours,  urinary  disorders,  and  as  an 
emmenagogue2.    Some  chemical  work  on 
the  plant  has  been  reported  3,4,5.  The 
present  study  deals  with  the  effect  of  the 
alcoholic  extract  of  the  aerial  parts  of  the 
plant on estrous cycle, hormonal profile and 
immunomodulation in mice. 
 
MATERIALS AND METHODS  
 
Sample  Preparation:  Properly  identified 
specimens  of  fagonia  cretica, (aerial  parts) 
were powdered and defatted with petroleum 
ether (60
o-80
o). After thoroughly extracting 
with  alcohol  in  a  soxhlet  apparatus,  the 
extract was dried and made into suspension 
with  distilled  water  using  carboxy  methyl 
cellulose  (CMC)  (0.5%)  as  suspending 
agent. 
 
Animals: Charles Foster albino rats of both 
sexes,  inbred  in  the  animal  house, 
maintained  in  air  conditioned  room  (25 
±2
oC) on a 14:10 hours light: dark cycle and 
the  relative  humidity  of  about  60%  were 
used. They were fed on a standard pellet diet 
(Lipton  Indian  Ltd)  with  free  access  to 
water. 
 
Effect on Estrous cycle: Eight adult healthy 
female rats (150-160g) were acclimatized to 
animal  house  condition  for  a  week  before 
starting of the experiment and divided into 
two groups (test group and control group) of 
4  animals  in  each  group.  Suspension  of 
alcoholic extract (100 mg/kg body weight) 
was fed orally through rubber catheter once 
daily  throughout  the  duration  of  the 
experiment  (18  days)  to  the  test  group  of 
animals whereas the animals of the control 
group  received  distilled  water  containing 
0.5%  CMC  as  placebo.  Changes  in  the 
phases of the estrous cycle were monitored 
carefully by vaginal smear method6 and the 
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disappearance  indices  of  different  phases 
were calculated
7 (Table I)  
 
Effect  on  implantation:  The  female  rats 
(150- 160 g each) were caged with male rats 
of  known  fertility  on  the  evening  of 
proestrus,  the  presence  of  copious 
spermatozoa  in  the  vaginal  smear  in  the 
following morning was counted as day 1 of 
the pregnancy. The suspension of the sample 
was administered to the pregnant rats orally 
from  day  1  to  day  10  of  pregnancy. 
Laparotomy  was  per  formed  on  day  11 
under light ether anaesthesia and the number 
of implantation sits in the uterine horn was 
recorded. Animals with at least one normal 
foetus  were  considered  as  pregnant,  the 
abdomen  was  sutured  and  the  rats  were 
returned to their cages, after parturition, the 
number of litters was counted the delivered 
pups were observed for at least, one month 
for  any  gross  malformations.  A  group  of 
pregnant  rats  which  received  vehicle  only 
served as control. (Table II). 
 
Estrogenic/Antiestrogenic activities:  
 
These were determined on immature female 
rats (40-50g) animals were divided into four 
groups, each group comprising five animals. 
The various groups received the treatment as 
follows: 
 
Group  I:  Oestradiol  valerate  0.1µg/rat/day 
s.c in groundnut oil (0.05ml). 
 
Group II: 0.05 ml of groundnut oil s.c 
 
Group  III:  Suspension  of  drug  sample   
250mg/kg p.o 
 
Group IV: Oestradiol valerate 0.1 µg/rat/day 
s.c  in  groundnut  oil  and  suspension  of 
sample 250 mg/kg p.o 
 
The treatment was given for 3 days and 24 
hours after the last treatment, the rats were 
sacrificed.  The uteri excised, cleared of the 
adhering tissues and weighed. (Table III). 
 
Progestational/  antiprogestational 
activities: 
 
These  were  assessed  by  the  pregnancy 
maintenance  test  in  pregnant  rats 
overiectomized  on  the  12
th  day  of 
pregnancy
8 Overiectomized rats which bore 
normal  implantation  were  regrouped  into 
four  groups  of  six  rats  in  each  group  and 
treated according to the following schedule: 
 
Group I: 0.05ml groundnut oil/rat days s.c 
 
Group II: Progesterone 2 mg/rat/day s.c in 
groundnut oil. 
 
Group III: Suspension of sample, 250 mg/kg 
p.o. 
 
Group IV: Progesterone 2 mg/rat/day s.c in 
groundnut  oil  and  sample  suspension  250 
mg/kg p.o. 
 
Treatment was given from day 12 to day 19 
of  pregnancy.  Autopsy  of  the  rats  was 
performed on day 20 and the number of live 
foetus  was  recorded.  The  results  were 
expressed  as  the  percentage  of  foetal 
survival. (Table IV). 
 
      No. of live foetus 
%  Foetal  Survival  =  --------------------------
  x 100 
          Total no. of implantation  
 
Androgenic/ Antiandrogenic activities:  
 
These were assessed in immature male rats 
(40-50g) divided into 4 groups of six rats in 
each, receiving the treatment as follows: 
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Group I: 0.05ml groundnut oil s.c 
 
Group  II:  Testosterone  propionate  150 
µg/rat/day s.c in groundnut oil. 
 
Group III: Suspension of sample, 250 mg/kg 
p.o. 
 
Group  IV:  Testosterone  propionate150 
µg/rat/day s.c in groundnut oil and sample 
suspension 250 mg/kg. p.o. 
 
The  Treatment  was  given  for  7  days.  The 
rats were sacrificed 24 hours after the last 
treatment.  Ventral  prostate  and  seminal 
vesicles  were  carefully  removed  from  the 
animals  and  quickly  weighted.  The  results 
are tabulated in table V. 
 
Immunomodulation studies 
 
For this, first the in vitro antibacterial effect 
of  the  suspension  of  the  extract  was  per 
formed, the suspension was incubated with 
E.coli (3.8x108 CFU) in nutrient broth at the 
concentration  of  1  mg  500  µg  250µg  and 
100 µg per ml. 
 
After incubation at 37
o C, the cultures were 
diluted, uniformly plated on McConky Agar 
plates  and  the  number  of  colonies  was 
counted. 
 
This  was  followed  by  conduction  in  Vivo 
studies  on  mice  following,  challenge  by 
E.Coli. The suspension was administered to 
inbred mice (20-25g: 6-8 weeks) at a dose of 
100 mg/kg once a day intra – peritonially for 
7 days. After the last dose, a lethal dose of 
E.coli  (3.8  x  108  CFU/mice)  was 
administered and survival data was recorded 
(Table VI). 
 
RESULTS AND DISCUSSION  
 
It is evident from table I, that fagonia cretica 
induces as distortion in the regularity of the 
estrous  cycle  of  the  rats  in  which  there  is 
random omission of the heat period (estrous 
phase).  Its  disappearance  index  +53.33 
which  accounts  for  the  reduction  of  the 
desire of the females  to mate with  makes. 
When  administered  in  the  dose  of  250 
mg/kg p.o it significantly acted as an anti-
implantation agent (Table II). 
Table  III  presents  its  estrogenic  and 
antiestrogenic  activities.  The  mean  uterine 
weight of the control group was 54.85 ±1.2 
mg/100gm  body  weight  and  estradiol 
valerate  at  dose  of  0.1  µg/rat/day  s.c  in 
groundnut  oil  produced  a  very  significant 
increase in the uterine weight compared to 
the control value. Sample suspension given 
by oral route at a dose of 250 mg/kg, failed 
to  produce  any  significant  change  in  the 
uterine weight indicating the absence of any 
estrogenic  activity.  Also,  no  significant 
change in the uterine weight was observed 
when  sample  suspension  and  estradiol 
valerate were given together as compared to 
the  value  obtained  with  estradiol  valerate 
treatment  alone,  So  any  antiestrogenic 
activity was also ruled out. 
 
The presence of any progestational activity 
is  also  lacking  with  sample  suspension 
(Table IV) since the extract failed to sustain 
the pregnancy of he rats ovariectomized on 
day  12  of  pregnancy.  On  the  contrary  the 
sample suspension seems to possess potent 
anti- progestational activity, since it nullified 
the effect of progesterone (Group IV).  The 
foetal survival percent with progesterone is 
91.1  whereas  with  the  combination,  it  is 
13.04% (Table IV). 
 
The  drug  suspension  has  significant 
androgenic actively (Table V) as the weights 
of both seminal vesicles and ventral prostate 
in-creased  in  comparison  to  the  control 
value.  It  does  not  seem  to  possess  any 
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antiandrogenic  activity  as  the  values 
obtained  by  treatment  with  testosterone 
propionate  were  no  significantly  altered 
when the combination of the two was given. 
 
The  summarize  suspension  of  alcoholic 
extract of fagonia cretica seems to possess 
strong antiprogestational activity with some 
androgenic activity. 
 
The lack of in vitro antibacterial activity and 
the  positive  in  vivo  protection  afforded  to 
the host by the pretreatment with the sample 
suspension (Table Vi) suggest that the drug 
possesses  possible  immuno-boosting 
property. 
 
Judging from the aforesaid results it is clear 
that  fagonia  cretica  has  good  antifertility 
potential in as much as it possesses strong 
anti-implantation,  anti-progestational  and 
some  degree  of  androgenic  activity. 
Immunoboosting  property  might  be  due  to 
action of the drug at the level of macrophage 
lymphocyte  or  compliment  activation  to 
enable  the  host  to  develop  resistance  to 
biological challenge, However it needs to be 
investigated further. 
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Table – 1 
Occurance of different phases in estrous cycle observed for all the animals in control and test 
group for the total period of 18 days following treatment with alcoholic extract of fagonia 
cretica. 
Phase  Control group  Test Group  Disappearance Index 
Estrus 
Metestrus 
Diestrus 
Proestrus  
15 
14 
30 
13 
7 
16 
34 
15 
+53.33 
-14.29 
-13.39 
-15.38 
 
Table – II 
Anti-implantation activity of alcoholic extract of Fagonia cretica in rats 
Extract  Dose  mg/kg 
p.o 
No.  Pregnant 
rats/  Total  No. 
of rats 
No.  of 
implantation 
sits (Mean) 
% Activity 
Control 
 
Alcoholic  extract  of 
F. cretica 
- 
 
 
250 
4/4 
 
 
0/4 
9,7,9,8,(8.0) 
 
 
0,0,0,0(0.0) 
0.0 
 
 
100.00 
 
Table – III 
Estrogenic / Antiestrogenic activity of alcoholic extract of fagonia cretica in immature female 
rats. 
S. 
No 
Treatment  Dose  Body  Weight 
(gm) 
Weight  of 
uterus (mg/100g 
body weight) 
1. 
 
Control 
 
0.05 ml groundnut oil 
 
42,45,40,40,43 
 
54.35 ±1.20 
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2. 
 
3. 
 
 
4. 
Oestradiol valerate 
 
Suspension  of  alcoholic 
extract of F. cretica 
 
Oestradiol  valerate 
sample suspension 
0.1µg/rat/day s.c  
 
250 mg/kg. p.o. 
 
 
0.1µg/rat/day s.c  
+250 mg/kg. p.o. 
40,45,47,40,42 
 
45,45,40,46,40 
 
 
40,43,45,42,45 
302.6 ± 6.14 
 
58.43 ± 1.6 
 
 
310.4 ± 5.6 
 
Table – IV 
Progestational/Anti-progestational activity of alcoholic extract of Fagonia cretica in pregnant 
female rats overiectomized on day 12 of pregnancy. 
 
S.No  Treatment  Dose  No.  of 
Implantation  sits 
(mean) 
No.  of  Live 
fetuses (mean) 
Fetal 
survival 
% 
1. 
 
2. 
 
3. 
 
 
 
4. 
Control 
 
Progesterone 
 
Suspension  of 
alcoholic extract of 
F. cretica 
 
Progesterone + 
Sample suspension 
- 
 
2µg/rat/day s.c  
 
250 mg/kg. p.o. 
 
 
 
2µg/rat/day s.c  
+250  mg/kg. 
p.o. 
 
8,9,9,10,9(9) 
 
10,9,10,8,8(9) 
 
8,8,10,11,9,(9.2) 
 
 
 
9,9,11,9,8 (9.2) 
0.0 
 
8,8,9,8,8 (8.2) 
 
0,0,0,0,0 (0) 
 
 
 
3,1,0,0,2 (1.2) 
0 
 
91.1 
 
0 
 
 
 
13.04 
 
Table – V 
Androgenic/Anti-androgenic activities of alcoholic extract of Fagonia cretica. 
 
S.No  Treatment  Dose  Weight mg/100g body weight 
Seminal vesicles  Ventral prostate 
1. 
 
2. 
 
 
3. 
 
 
 
4. 
Control 
 
Testosterone 
progesterone 
 
Suspension  of 
alcoholic  extract  of  F. 
cretica 
 
Testosterone 
progesterone + 
Sample suspension 
Oil Only 
 
150µg/rat s.c  
 
 
250 mg/kg. p.o. 
 
 
 
 
150 µg/rat s.c  
+250 mg/kg. p.o. 
 
24.3 ± 0.4 
 
189.6 ± 2.8 
 
 
86.2 ± 1.7 
 
 
 
 
203.7 ± 2.3 
30.4 ± 0.6 
 
123.6 ± 0.4 
 
 
65.1 ± 0.7 
 
 
 
 
127.3 ± 1.9 
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Table – VI 
Immunoprotective effect of alcoholic extract of Fagonia cretica in mice against E.coli challenge 
 
Fraction 
 
Dose of 
E.coli 
 
Day 
7 
 
Day 
8 
Day 
9 
 
Day 
10 
 
Day 
11 
 
Day 
12 
 
Day 
13 
 
Day 
14 
 
Control 
 
 
Suspension  of 
alcoholic extract of F. 
cretica 
3.6 x10
8 
CFU/mice 
 
3.6 x10
8 
CFU/mice 
4 
 
 
4 
4 
 
 
4 
0 
 
 
4 
- 
 
 
4 
- 
 
 
4 
- 
 
 
4 
- 
 
 
4 
- 
 
 
4 
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